PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 55 filers reported holding PASSAGE BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,000 | -60.0% | 20,435 | -48.0% | 0.00% | – |
| Q2 2023 | $30,000 | -18.9% | 39,323 | -18.0% | 0.00% | – |
| Q1 2023 | $37,000 | -26.0% | 47,983 | +12.0% | 0.00% | – |
| Q4 2022 | $50,000 | -2.0% | 42,834 | -17.9% | 0.00% | – |
| Q3 2022 | $51,000 | -58.9% | 52,157 | -5.1% | 0.00% | – |
| Q2 2022 | $124,000 | +3.3% | 54,983 | +35.5% | 0.00% | – |
| Q1 2022 | $120,000 | -35.8% | 40,577 | +44.0% | 0.00% | – |
| Q4 2021 | $187,000 | -12.6% | 28,170 | +30.0% | 0.00% | -100.0% |
| Q3 2021 | $214,000 | +20.2% | 21,669 | +61.7% | 0.00% | 0.0% |
| Q2 2021 | $178,000 | – | 13,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
| Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
| Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
| Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
| Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
| Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
| Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |